AllianceBernstein
ERAS icon

AllianceBernstein’s Erasca ERAS Stock Holding History

AllianceBernstein’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.84M Buy
2,644,920
+2,436,110
+1,167% +$28.8M ﹤0.01% 1216
2025
Q4 		$777K Sell
208,810
-24,620
-11% -$69.2K ﹤0.01% 2448
2025
Q3 		$509K Hold
233,430
– – ﹤0.01% 2663
2025
Q2 		$296K Buy
233,430
+78,940
+51% +$106K ﹤0.01% 2917
2025
Q1 		$212K Hold
154,490
– – ﹤0.01% 2905
2024
Q4 		$388K Hold
154,490
– – ﹤0.01% 2750
2024
Q3 		$422K Hold
154,490
– – ﹤0.01% 2749
2024
Q2 		$365K Buy
154,490
+36,180
+31% +$78.1K ﹤0.01% 2834
2024
Q1 		$244K Hold
118,310
– – ﹤0.01% 2878
2023
Q4 		$252K Hold
118,310
– – ﹤0.01% 2913
2023
Q3 		$233K Buy
118,310
+6,120
+5% +$15.7K ﹤0.01% 2906
2023
Q2 		$310K Sell
112,190
-82,500
-42% -$235K ﹤0.01% 2848
2023
Q1 		$586K Sell
194,690
-1,800,275
-90% -$6.55M ﹤0.01% 2489
2022
Q4 		$8.6M Sell
1,994,965
-2,148,159
-52% -$14.6M ﹤0.01% 1176
2022
Q3 		$32.3M Buy
4,143,124
+77,295
+2% +$623K 0.02% 681
2022
Q2 		$22.6M Buy
4,065,829
+672,098
+20% +$4.4M 0.01% 822
2022
Q1 		$29.2M Buy
3,393,731
+137,085
+4% +$1.59M 0.01% 772
2021
Q4 		$50.7M Buy
3,256,646
+729,615
+29% +$12.5M 0.02% 619
2021
Q3 		$53.6M Buy
+2,527,031
New +$52.1M 0.02% 597

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

AllianceBernstein's ERAS Position: Q1 2026 in Review

AllianceBernstein increased its Erasca (ERAS) stake by 1,167% in Q1 2026, buying an estimated $28.8M and bringing the position to 2,644,920 shares worth $9.84M. The position accounts for ﹤0.01% of the portfolio, ranked #1216.

AllianceBernstein first reported a position in ERAS in Q3 2021 and has held it in 19 quarters since. The position peaked at $53.6M in Q3 2021. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • AllianceBernstein held 2,644,920 shares of Erasca worth $9.84M as of Q1 2026.
  • AllianceBernstein bought 2,436,110 Erasca shares in Q1 2026, an estimated $28.8M.
  • Erasca made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #1216 holding.
  • AllianceBernstein first reported a position in Erasca in Q3 2021 and has held it in 19 quarters since.
  • AllianceBernstein's Erasca position peaked at $53.6M in Q3 2021.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.